Overview
- Cigna reported 2025 revenue up 11% to $274.9 billion, with fourth-quarter revenue up 10% to $72.4 billion driven by Evernorth and specialty pharmacy growth.
- Full-year net income reached about $5.95 billion, while fourth-quarter net income fell to $1.2 billion from $1.4 billion a year earlier, with 2024 comparisons affected by a prior one-time investment loss.
- The medical cost ratio rose to 87.9% in the fourth quarter and 84.4% for the year, up from 83.2% in 2024, reflecting higher costs in individual and family plans.
- Fourth-quarter adjusted earnings per share of $8.08 and revenue of $72.4 billion topped Wall Street estimates of $7.88 and $70.3 billion, respectively.
- Management guided to 2026 revenue of about $280 billion and adjusted EPS of at least $30.25, both below consensus, and projected an MCR of 83.7%–84.7% versus the 83.9% analysts expected.